CDC42 and bone neoplasm: Also, in the pathogenesis of Ewing Sarcoma, a highly aggressive bone tumour, miR‐130b was reported to induce proliferation, invasion, and migration in vitro and increase metastatic potential via activation of the Cdc42 and Pak1 pathway.36